80 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
.
Year Ended December 31,
(in thousands)
Audit Fees(1)
Audit-Related Fees
Tax Fees
All Other Fees
Total Fees
Audit fees consist of fees … all of the audit, audit-related, tax and other services provided by EY for 2023 and 2022, including the audit, audit-related, tax and other services
8-K
EX-99.1
1ah0646
12 Mar 24
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
4:06pm
SC TO-I
EX-99
y2v45
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
gdg hu3sqi5
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
c40djj6uomj10
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
jf8j9y01zyd
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
ruil9l5hqhqv2i
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
u042ng3pysvj14j
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
hcfb1f7i6lsd
30 Jan 24
Issuer tender offer statement
7:04am
8-K
EX-99.1
3ml wv1eys
2 Nov 23
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results
4:05pm
8-K
EX-4.1
mbrl6c8h
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-4.2
mlyw3qqjaea 7bil0q9q
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
ske51 apmy22u5j
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm